Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP1.4979 in Adult Patients With Essential Tremor
NCT07074002Phase 2Recruiting
- Sponsor
- Bioprojet
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BP-1.4979 in essential tremor (ET), sponsored by Bioprojet. Started Sep 2025; status: recruiting.
02
Drugs
BP-1.4979
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT07074002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07074002.